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We	describe	a	laboratory-confirmed	case	of	hantavirus	
infection	in	the	Republic	of	Georgia.	Limited	information	is	
available	about	hantavirus	infections	in	the	Caucasus,	al-
though the infection has been reported throughout Europe 
and	Russia.	Increasing	awareness	and	active	disease	sur-
veillance contribute to our improved understanding of the 
geographic range of this pathogen.
R
odent-borne  hantavirus  infections  causing  hemor-
rhagic  fever  with  renal  syndrome  (HFRS)  occur 
throughout most of Europe and Russia. The pathogenic 
hantaviruses detected in Europe and Russia include Puu-
mala, Dobrava, Saaremaa, Tula, Amur, and Hantaan vi-
ruses (1,2). Seroprevalence studies of hantavirus infection 
in Europe have shown prevalence rates as high as 6%–9% 
in Sweden, Estonia, and European Russia (1). The circu-
lation of hantaviruses is specific predominantly to rodent 
species and thus correlates with the host range of the ro-
dent reservoir. Several lineages of Dobrava virus circulate 
in Europe and Russia (3–6), and are named according to 
their rodent reservoirs: Apodemus flavicollis (Dobrava-
Af), A. agrarius (Dobrava-Aa), and A. ponticus (Dobra-
va-Ap). Dobrava-Aa is suspected to be the predominant 
strain in central Europe (7).
The  clinical  manifestations  of  hantavirus  infection 
vary and depend largely on the strain of the infecting virus. 
Classic HFRS is characterized by fever, acute renal failure, 
hypotension, hemorrhage, and vascular leakage. Puumala 
virus typically induces a mild variant of HFRS (nephro-
pathia epidemica) accompanied by high fever, headache, 
backache, and abdominal pain. Mild hemorrhagic mani-
festations, including conjunctival hemorrhage or petechi-
ae on the trunk or palate, also may occur. Severe clinical 
manifestations are rare (<1% of patients) but can include 
acute renal failure, severe neurologic manifestations, and 
death (8). Dobrava-Aa may induce a similarly mild clinical 
course of illness to that of Puumala virus (6).
Information is scant about hantaviruses in the Repub-
lic of Georgia. Although reports of hantavirus infection 
from other countries in the surrounding area suggest that 
this pathogen circulates in the Caucasus, the incidence of 
these infections is unknown.
The Patient
A 31-year-old male resident of Tbilisi, Georgia, sought 
treatment at the Infectious Pathology, AIDS and Clinical 
Immunology Center in early June 2008, six days after on-
set of illness. At that time, he was enrolled in an ongoing 
laboratory-based surveillance study of acute febrile illness 
(AFI). Initial clinical symptoms were fever (maximum ax-
illary temperature 39°C), arthralgias and myalgias in the 
lower extremities, back pain, vomiting, and diffuse abdom-
inal pain. Vital signs indicated a pulse rate of 87 bpm and 
blood pressure of 140/80 mm Hg. The physical examina-
tion noted mild hepatosplenomegaly and pharyngeal injec-
tion. The chest radiograph and ultrasound of the abdomen 
were normal. No preexisting illnesses were reported. Trav-
el history included regular trips to Marneuli district (a rural 
district south of Tbilisi). No specific rodent exposures were 
noted, and no other travel was reported.
Laboratory  findings  were  normal,  with  the  excep-
tion of elevated band neutrophils (20%, reference range 
1%–6%) and lymphocytosis (44%, reference range 19%–
37%). C-reactive protein level was elevated (48.9 mg/mL, 
reference range <6 mg/mL), and decreased total protein 
(62 g/L, reference range 65–85 g/L) and albumin levels (20 
g/L, reference range 35–50 g/L) were observed. Results of 
liver function tests and serum creatinine levels were within   
normal limits.
An elevated creatinine level (214 μmol/L, reference 
range 53–115 μmol/L) was noted on day 9 of illness, along 
with a decrease in urine output. Proteinuria (3 g/24 h), mi-
croscopic hematuria, and elevated blood pressure (160/90 
mm Hg) were also observed. The patient was transferred 
to the nephrology department of the Institute of Urology 
in Tbilisi with a diagnosis of acute renal failure. Patient’s 
fluid input and output were closely regulated, and his con-
dition improved gradually without dialysis.
Serum samples were tested for antibodies against a 
panel of pathogens, including Salmonella enterica serovar 
Typhi, S. paratyphi A and B, Epstein-Barr virus, Brucella 
spp., Coxiella burnetti, hantavirus, Rickettsia (spotted fe-
ver and scrub typhus groups), West Nile virus, tick-borne 
encephalitis virus, and Leptospira spp. All serologic test 
results were negative except for the test result for hantavi-
rus. To corroborate hospital laboratory diagnostics, serum 
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by using Western blot assay (recomBlot Bunyavirus immu-
noglobulin [Ig]G/IgM; Mikrogen, Neuried, Germany) and 
immunofluorescence antibody (IFA) assay (Progen, Heidel-
berg, Germany). Results from the Western blot assay were 
negative for Puumala IgG and positive for Hantaan IgG and 
Dobrava IgM. The IFA result for Hantaan antibodies was 
positive at a reciprocal titer >2,048. The Naval Medical 
Research Unit No. 3 in Egypt conducted a hantavirus IgM 
ELISA (Focus Diagnostics, Cypress, CA, USA) on paired 
serum samples (acute-phase sample positive:negative ratio 
= 8.42; convalescent phase = 7.815, cut-off 1.10). Results 
of blood and Leptospira spp. cultures were negative. A re-
nal biospy specimen obtained 10 days after disease onset 
showed acute tubular necrosis with mild-grade arteriolo-
sclerosis (Figure).
On the 11th day of illness, the patient’s general con-
dition  started  to  improve,  with  increased  urine  output, 
resolution of abdominal pain, and normalization of blood 
pressure (120/70 mm Hg). No sequelae were reported at 
1-month follow-up.
Conclusions
The clinical presentation and results of serologic tests 
for this patient who had renal failure but no apparent hem-
orrhage were consistent with results previously described 
for hantavirus infection. Although the differential diagno-
sis included other infectious and noninfectious causes of 
renal failure including leptospirosis, ongoing surveillance 
of AFI in Georgia provided the serologic testing capabil-
ity that enabled clinicians to identify a hantavirus infection 
as the cause of this illness characterized by high fever and 
evidence of renal dysfunction (increased serum creatinine, 
proteinuria, and hematuria).
The pathologic changes observed in hantavirus infec-
tion  presumably  result  from  increased  vascular  perme-
ability, characterized clinically by elevated hematocrit and 
decreased serum protein levels. Damage to the vascular 
endothelium along with cytokine-induced renal tubular and 
interstitial pathologic changes may partially explain renal 
failure associated with hantavirus infection. Although the 
most  commonly  noted  renal  pathologic  finding  is  acute 
interstitial nephritis, acute tubular cell necrosis is also de-
scribed. A comparative study of Puumala and Dobrava re-
nal pathology noted increased intensity and extent of med-
ullary interstitial capillary injury, hemorrhages, and tubular 
necrosis among Dobrava virus-infected patients (9).
The strain of the infecting virus is unknown, but se-
rologic results, along with the available information from 
surrounding countries, implicate Dobrava virus as the in-
fecting strain. The relatively mild clinical symptoms of this 
patient suggest that a variant of Dobrava virus, or a closely 
related  hantavirus  strain  that  cross-reacts  with  Dobrava, 
may be the etiologic agent. Information about the circulat-
ing virus strains, clinical manifestation, rodent hosts, and 
disease prevalence are lacking for the Caucasus. Further 
studies are needed on potential rodent hosts and character-
ization of circulating strains.
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